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collection of alternative amino acid substitutions were made at this site and the
properties of the mutant viruses determined. Only the presence of a positively charged
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enterovirus morphogenesis. These results have implications for the testing of potential
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Abstract 26 
The foot-and-mouth disease virus (FMDV) capsid precursor, P1-2A, is cleaved by FMDV 3C 27 
protease to yield VP0, VP3, VP1 and 2A. Cleavage of the VP1/2A junction is the slowest. Serotype 28 
O FMDVs with uncleaved VP1-2A (having a K210E substitution in VP1; at position P2 in cleavage 29 
site) have been described previously and acquired a second site substitution (VP1 E83K) during virus 30 
rescue. Furthermore, introduction of the VP1 E83K substitution alone generated a second site change 31 
at the VP1/2A junction (2A L2P, position P2' in cleavage site). These virus adaptations have now 32 
been analysed using Next Generation Sequencing to determine sub-consensus level changes in the 33 
virus; this revealed other variants within the E83K mutant virus population that changed residue VP1 34 
K210. The construction of serotype A viruses with a blocked VP1/2A cleavage site (containing 35 
K210E) has now been achieved. A collection of alternative amino acid substitutions were made at 36 
this site and the properties of the mutant viruses determined. Only the presence of a positively charged 37 
residue at position P2 in the cleavage site permitted efficient cleavage of the VP1/2A junction, 38 
consistent with analyses of diverse FMDV genome sequences. Interestingly, in contrast to the 39 
serotype O virus results, no second site mutations occurred within the VP1 coding region of serotype 40 
A viruses with the blocked VP1/2A cleavage site. However, some of these viruses acquired changes 41 
in the 2C protein that is involved in enterovirus morphogenesis. These results have implications for 42 
the testing of potential antiviral agents targeting the FMDV 3C protease.                          43 
 44 
Introduction 45 
Foot-and-mouth disease virus (FMDV) is the prototypic member of the Aphthovirus genus within the 46 
family Picornaviridae and seven different serotypes (O, A, C, SAT 1-3 and Asia-1) have been 47 
identified. All FMDVs have a positive sense RNA genome (ca. 8400 nt) that includes a single large 48 
open reading frame (ca. 7000 nt) encoding a polyprotein (Belsham, 2005). The full-length polyprotein 49 
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is never observed since during, and after, synthesis it is processed, mainly by virus-encoded proteases, 50 
to generate 15 distinct mature products plus multiple precursors. The FMDV polyprotein includes 51 
two trans-acting proteases; these are the Leader (L) protease and the 3C protease (3Cpro). The L 52 
protease is only responsible for one cleavage within the polyprotein that occurs at its own C-terminus 53 
(i.e. the L/P1-2A junction, Strebel & Beck, 1986; Medina et al., 1993). However, this protease also 54 
induces cleavage of the translation initiation factor eIF4G, this results in the inhibition of host cell, 55 
cap-dependent, protein synthesis (reviewed in Belsham, 2005). The 3Cpro cleaves all the other 56 
junctions within the FMDV polyprotein except for the VP4/VP2 junction and the 2A/2B junction. 57 
Cleavage of VP0 to VP4 and VP2 occurs on encapsidation of the viral RNA and also within 58 
assembled empty capsid particles (Curry et al., 1995; Gullberg et al., 2013a; Gullberg et al., 2013b). 59 
Separation of the 2A peptide from the 2B protein is dependent on the 2A coding sequence. However, 60 
this region only encodes 18 amino acids (without any protease motifs) but its presence results in a 61 
break in the polyprotein during its synthesis; this is described as “ribosomal skipping” (Donnelly et 62 
al., 2001) or “StopGo” (Atkins et al., 2007).  63 
The FMDV capsid protein precursor, P1-2A (Fig. 1), is processed by the 3Cpro to VP0, VP3, VP1 and 64 
2A. The scission of the VP1-2A junction is the slowest of these cleavages within cell-free translation 65 
systems (Ryan et al., 1989) and within mammalian cells (Gullberg et al., 2013a; Gullberg et al., 66 
2013b) since the uncleaved VP1-2A can still be detected when all other junctions are fully cleaved 67 
(e.g. when P1-2A is expressed with a low-level of 3Cpro). However, in peptide cleavage assays, using 68 
short synthetic substrates, it has been found that the peptide corresponding to the VP1/2A cleavage 69 
site was the most rapidly processed (Birtley et al., 2005). 70 
The FMDV 3Cpro cleaves a variety of different junction sequences (the amino acid residues at the 71 
cleavage junctions are indicated as: P4P3P2P1/P1'P2'P3'P4'). The cleavage sites recognized by the 72 
FMDV 3Cpro have either glutamine (Gln, Q) or glutamate (Glu, E) at the P1 position (Curry et al., 73 
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2007). The consensus sequence (in single letter code) for the VP1/2A junction in serotype O and A 74 
FMDVs is PxKQ/xLNF. The Q residue at the P1 position together with the P4-Pro (P), P2-Lys (K) 75 
and P4´-Phe (F) residues, represent key determinants of 3Cpro specificity at this site (Birtley et al., 76 
2005; Curry et al., 2007; Zunszain et al., 2010). Analysis of aligned FMDV 3Cpro cleavage sites from 77 
over 100 strains of the virus (including representatives of all serotypes) revealed that sites with P1-Q 78 
have a strong selectivity for P2-K, indicating that recognition of the P1 residue by 3Cpro is influenced 79 
by the P2 residue (Curry et al., 2007). Recently, we have shown that changing the P2-K residue to E 80 
at the VP1/2A junction (i.e. K210E in VP1), in a serotype O virus, greatly inhibited cleavage at this 81 
junction and resulted in the formation of infectious virus particles containing the uncleaved VP1-2A 82 
(Gullberg et al., 2013b). The “self-tagged” viruses containing this modification (K210E) also 83 
acquired, during the virus rescue procedure, a second amino acid substitution within VP1 (E83K). 84 
Interestingly, introduction of this E83K substitution alone into the virus, generated a second site 85 
mutant (L2P, in the 2A sequence; this is position P2' in the VP1/2A junction) that also blocked 86 
cleavage (Gullberg et al., 2014). We have now expanded this analysis to identify the determinants of 87 
cleavage at the VP1/2A junction within the context of infectious serotype O and A FMD viruses using 88 
a variety of different approaches. Within the serotype A FMDVs, no second site changes in VP1 were 89 
observed in viruses where the VP1/2A cleavage was inhibited, but some evidence for changes in 2C 90 
was obtained. For certain picornaviruses, within the enterovirus genus, interactions between the virus 91 
capsid proteins and the 2C non-structural protein have been implicated in the process of virus 92 
morphogenesis (Liu et al., 2010; Wang et al., 2012; Wang et al., 2014). 93 
 94 
Results  95 
Modification of the VP1/2A cleavage site in a serotype A FMDV. 96 
In order to determine whether the key elements of the results obtained with the serotype O FMDV 97 
sequences (Gullberg et al., 2014) also applied to serotype A FMDV, the effect of modifying the 98 
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VP1/2A cleavage site within a serotype A FMDV was examined. The VP1/2A cleavage site sequence 99 
in the A22 strain of FMDV (APAKQ/LLNFD) differs at just 1 out of the 10 residues flanking the 100 
junction from the serotype O (strain O1 Manisa, abbreviated thoughout as O1M) sequence 101 
(APVKQ/LLNFD) analysed previously (Gullberg et al., 2013b; Gullberg et al., 2014) (see Fig. 1). 102 
The K210E substitution (at the P2 position) was introduced into a full-length FMDV cDNA, based 103 
on the backbone of a chimeric O1 Kaufbeuren (O1K) virus containing the coding sequence for the 104 
VP2-VP3-VP1-2A region of the A22 capsid protein precursor (Fig.1). Virus was successfully rescued 105 
from this chimeric wt O1K/A22 plasmid and also from the O1K/A22 VP1 K210E mutant (this had 106 
changed the codon encoding VP1 residue 210 from AAA to GAA). However, when the capsid protein 107 
coding sequences within the rescued virus were determined, it was found that the K210E substitution 108 
in VP1 had reverted in the virus by passage 2 (Psg 2) to the wt sequence (this only requires a single 109 
nt change) (see Fig. 1). 110 
Two further modifications were, therefore, introduced into the serotype A viruses, the 2A L2P 111 
modification was made in isolation (using 3 nt changes, TTG to CCA) and a double mutant containing 112 
both the K210E substitution (the single nt change) and the 2A L2P substitution. Viruses were rescued 113 
successfully from both of these mutant plasmids. Consensus sequencing indicated that the expected 114 
mutations were still present within these rescued viruses and that no other mutations were detected 115 
within the VP2-2A coding region (see Fig. 1). 116 
Analysis of the FMDV capsid proteins within cells infected with the wt and mutant O1K/A22 viruses, 117 
as determined by immunoblotting using anti-VP2 and anti-2A antibodies, is shown in Fig. 2. As 118 
expected, the production of VP0 and VP2 was very similar in each of the infected cell extracts (Fig. 119 
2(a), lanes 2-7). However, the presence of the uncleaved VP1-2A was only observed with the mutant 120 
viruses, either containing the 2A L2P substitution alone (Fig. 2(b), lanes 4 and 5) or with the double 121 
mutant (VP1 K210E and 2A L2P) (Fig. 2(b), lanes 6 and 7). 122 
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These results were confirmed using immunofluorescence (IF) studies (Fig. 3). Consistent with the 123 
immunoblotting data, the presence of FMDV 2A (still attached to VP1) was detected in cells infected 124 
with the O1K/A22 2A L2P mutant virus (Fig. 3(g)) and with the double mutant (O1K/A22 VP1 125 
K210E and 2A L2P) virus (Fig. 3(h)). In contrast, no signal for the 2A peptide was observed in cells 126 
infected with the wt O1K/A22 virus (Fig. 3(f)) or in uninfected cells (Fig. 3(e)). The presence of the 127 
FMDV capsid proteins could be detected in cells infected with each of the viruses (Fig. 3(b-d)) but 128 
not in uninfected cells (Fig. 3(a)). These results are consistent with those obtained using the serotype 129 
O FMDVs previously (Gullberg et al., 2014). It seems that the free 2A peptide is not efficiently 130 
detected within cells using the IF approach; it is assumed that either it breaks down very quickly or 131 
the conditions of the IF assay are not suitable for detection of this short peptide. 132 
 133 
Use of NGS to determine sequence diversity within rescued FMDVs. 134 
As described previously (Gullberg et al., 2013b; Gullberg et al., 2014), consensus sequencing of the 135 
capsid coding region (P1-2A) of the serotype O FMDVs rescued from the K210E and E83K mutant 136 
forms of the O1K/O1M cDNAs identified the presence of additional amino acid substitutions in the 137 
rescued viruses. We wished to analyse these adaptations in more detail, in particular to examine the 138 
appearance of sub-consensus level changes throughout the near complete genome sequence including 139 
the complete polyprotein coding region. To achieve this, RNA was extracted from the rescued 140 
O1K/O1M VP1 E83K and O1K/O1M VP1 K210E viruses (as described by Gullberg et al., 2013b; 141 
Gullberg et al., 2014) at Psg 2 and/or Psg 3. Two separate, but overlapping, cDNA fragments 142 
including the near complete genome (ca. 8kb, downstream of the poly(C) tract) were produced by 143 
RT-PCR, mixed and then sequenced using NGS at a coverage of about 5,000 reads per nt (except 144 
near the extreme 5'- and 3'-termini).  145 
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This analysis showed that the rescued virus O1K/O1M VP1 E83K retained the expected substitution 146 
(encoding E83K) in 100% of the progeny at Psg 2 but there was some heterogeneity in the sequence 147 
near the VP1/2A junction (see Table 1). As described earlier, the consensus sequencing indicated that 148 
a substitution (L2P) within the 2A sequence occurred within this rescued virus (Gullberg et al., 2014). 149 
The analysis by NGS (see Table 1) demonstrated that at Psg 2 some 83% of the reads corresponded 150 
to this L2P substitution in 2A while two other variants were also present (albeit at relatively low 151 
levels, 4% and 9%) which each encoded the K210N substitution in VP1 (c.f. the K210E change 152 
described previously in O1M, (Gullberg et al., 2014)). No other coding changes were present 153 
anywhere in the genome at an abundance of more than 3%. 154 
Consensus sequence analysis of the rescued O1K/O1M VP1 K210E virus has shown previously the 155 
generation of the E83K substitution (Gullberg et al., 2013b). Using NGS, it was found that the E83K 156 
substitution in VP1 was encoded in 78% of the reads generated at Psg 2 and in 99% of the reads at 157 
Psg 3 (Table 1), consistent with the earlier consensus sequencing (Gullberg et al., 2013b). The K210E 158 
substitution was maintained in this rescued virus in 100% of the reads at Psg 2 and Psg 3.  159 
For the rescued serotype A viruses, consensus (Sanger) sequencing of the rescued O1K/A22 2A L2P 160 
virus demonstrated the maintenance of the introduced changes and did not reveal any additional 161 
modifications resulting in amino acid substitutions within the P1-2A coding region. This was 162 
confirmed by NGS but an A to G nucleotide change, resulting in a single amino acid substitution 163 
(T44 to A within the 2C protein), was found in 13% of the reads from the rescued virus (Table 2). 164 
Within the O1K/A22 VP1 K210E and 2A L2P virus, only the expected changes in the P1-2A coding 165 
region were observed but an additional change, resulting in the amino acid substitution A73V in the 166 
2C protein, was detected in 100% of the sequence reads, see Table 2. The plasmid pO1K/A22 K210E 167 
L2P from which this virus was rescued has been confirmed as having the expected sequence in the 168 
2C coding region (100% identity to O1K, data not shown) and thus this sequence change had occurred 169 
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during virus rescue. The significance of these changes in 2C is unknown; neither residue is completely 170 
conserved among FMDV strains (Carrillo et al., 2005). The A73V change in 2C was not present in 171 
the rescued O1K/A22 wt or the O1K/A22 2AL2P and there was no evidence for the T44A amino acid 172 
substitution in either the O1K/A22 wt or the O1K/A22 VP1 K210E and 2A L2P virus that was 173 
encoded in a minority of the O1K/A22 2A L2P virus reads. 174 
 175 
Exploring potential sequence diversity at the VP1/2A cleavage site. 176 
The results described previously (Gullberg et al., 2013b; Gullberg et al., 2014) indicated that 177 
modification of the VP1/2A junction sequence from PxKQ/xLNF at the P2 position (from K to E) or 178 
the P2' position (from L to P) was sufficient to strongly inhibit cleavage by 3Cpro at this protein 179 
junction but these changes did not affect virus viability. Furthermore, the NGS data (Table 1) 180 
indicated that the K to N substitution at residue 210 of VP1 was also probably viable since some 13% 181 
of the virus population acquired this change. To establish the range of amino acid substitutions that 182 
could be tolerated at this junction, mutagenesis of the codon for residue 210 within VP1 was 183 
undertaken within the context of the O1K/A22 full-length cDNA. The mutagenesis generated 9 184 
different codon sequences that encoded 7 distinct amino acid substitutions, see Table 3. RNA 185 
transcripts were produced from the mutant cDNAs and electroporated into BHK cells and infectious 186 
viruses were rescued in each case. From the virus harvests, RNA was extracted and the sequence of 187 
VP1-2A coding region was determined, changes (if any) are shown in Table 3. Consistent with the 188 
studies described above, the O1K/A22 VP1 K210E mutant (with a single nt change, GAA) again 189 
reverted to the parental sequence, however when 2 nt changes were introduced (GAG) to produce the 190 
K210E substitution then viruses that retained these 2 nt changes were obtained. Thus the VP1 191 
substitutions K210Q, K210R, K210A, K210V, K210M, K210N and K210E (as the GAG double 192 
mutant) were all viable without reversion or other adaptation within VP1 (Table 3). Using consensus 193 
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level sequencing, no changes in the 2C coding region were detected in any of these rescued viruses 194 
either (data not shown). 195 
The cleavage of the VP1/2A junction in cells infected with the rescued mutant viruses was assessed 196 
using the IF assay, as described above. The presence of the FMDV capsid proteins (using anti-FMDV 197 
antisera) and of the VP1-2A (using anti-2A antibodies) was determined in BHK cells infected with 198 
the different viruses. FMDV infection, but with no staining for VP1-2A, was observed in cells 199 
infected with the viruses containing the VP1 residue K210 (wt) and R210 (Fig. 4). In contrast, cells 200 
infected with the rescued viruses having the substitutions in VP1 K210Q, K210A, K210V, K210M, 201 
K210N and K210E (double mutant) each showed staining both for the FMDV capsid proteins and for 202 
2A ( using the anti-2A antisera), indicative of blocked VP1/2A cleavage (see Fig. 4 and Table 3). No 203 
staining with either antiserum was observed in uninfected cells, as expected (Fig. 4). 204 
To confirm these results, immunoblotting was performed using anti-2A antibodies to determine the 205 
presence of the uncleaved VP1-2A within infected cells. The results are shown in Fig. 5(a). Consistent 206 
with the IF results, no VP1-2A product was detected in uninfected cells or in wt (K210) or mutant 207 
K210R FMDV-infected cells. In contrast, the presence of VP1-2A was readily apparent within cells 208 
infected with mutant FMDVs having the K210Q, K210A, K210V, K210M, K210N and K210E 209 
substitutions. The presence of FMDV capsid proteins in the lysates from cells infected with each of 210 
the different FMDV variants was verified using anti-VP2 antibodies that recognizes both VP0 and 211 
VP2 (Fig. 5(b)). These results support the IF data and indicate that the VP1/2A junction is only 212 
cleaved when residue 210 in VP1 is either K or R (these are both basic residues). 213 
 214 
Discussion  215 
In our earlier studies, it was shown that the K210E substitution in VP1 within the FMDV O1M capsid 216 
inhibited cleavage of the VP1/2A junction and resulted in generation of a second site substitution 217 
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(E83K in VP1) in the mutant virus (Gullberg et al., 2013b). Furthermore, introduction of the E83K 218 
substitution alone in VP1 resulted in the production of another second site change (with a substitution 219 
of L2P in 2A) that also blocked VP1/2A junction processing in cells infected with the rescued virus 220 
(Gullberg et al., 2014). In contrast, this study, has shown that when the K210E substitution (GAA 221 
mutant) was introduced into the VP1 of a serotype A virus (O1K/A22), the virus reverted to wt (AAA) 222 
very rapidly (single nt change). However, introduction of 2 nt changes (GAG codon) enabled the 223 
K210E substitution to be maintained. Consistent with the serotype O virus results (Gullberg et al., 224 
2013b; Gullberg et al., 2014), this amino acid substitution alone was sufficient to block VP1/2A 225 
cleavage (see Figs. 4 and 5). In addition, introduction of the 2A L2P change alone (employing 3 nt 226 
changes) or also with the K210E substitution resulted in the generation of viruses which maintained 227 
each of these changes. Furthermore, the presence of the uncleaved VP1-2A protein was observed 228 
within cells infected with these serotype A viruses (Figs. 2 and 3). Thus, consistent with results using 229 
the O1K/O1M FMDV (Gullberg et al., 2013b; Gullberg et al., 2014), it is possible to obtain infectious 230 
serotype A FMDVs, containing the uncleaved VP1-2A. However, in contrast to the results using the 231 
serotype O virus, there was no apparent selection for a substitution at residue E83 in VP1 (or 232 
elsewhere within the VP1) within the serotype A background. The basis for this difference is not 233 
known but it is noteworthy that the serotype A capsid proteins assemble into FMDV empty capsids 234 
much more efficiently than the serotype O proteins (Abrams et al., 1995; Porta et al., 2013). It is also 235 
apparent that some of the rescued serotype A viruses, with the VP1/2A junction rendered non-236 
cleavable, acquired second site mutations within the non-structural protein 2C (see Table 2). In 237 
particular, the A73V variant within 2C was encoded by 100% of the sequence reads at Psg 3 of the 238 
rescued O1K/A22 VP1-K210E and 2A-L2P virus. This suggests a strong selective pressure for this 239 
amino acid substitution. The significance of this is currently unknown but there is some evidence for 240 
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interactions between the capsid proteins and the 2C protein of enteroviruses (e.g. poliovirus) during 241 
virus morphogenesis (Liu et al., 2010; Wang et al., 2012; Wang et al., 2014). 242 
Interestingly, it was also observed, using NGS, that during the rescue of the O1K/O1M VP1 E83K 243 
virus a minority of the virus population encoded a K210N substitution in VP1 (c.f. the K210E 244 
substitution observed in a laboratory grown O1M virus, Gullberg et al., 2013b). It should be noted 245 
that the majority of the serotype O VP1 E83K mutant virus RNA acquired the 2A L2P substitution 246 
during the virus rescue procedure (see Table 1). This encouraged analysis of the range of substitutions 247 
that can be accommodated at residue 210 in VP1; this is at position P2 relative to the VP1/2A cleavage 248 
site. Within the serotype A background, there appears to be significant selection pressure against the 249 
K210E substitution, since following independent transfections of a mutant RNA containing a single 250 
nt change (GAA) reversion to the wt (AAA) sequence occurred. However, when 2 nt changes were 251 
used (GAG) to make this amino acid substitution then the K210E substitution was maintained. The 252 
single nt substitution to make the K210E substitution was also maintained in the O1K/A22 K210E 253 
and L2P double mutant; presumably the presence of the two substitutions that blocked VP1/2A 254 
cleavage overcame the selective pressure for reversion. In addition, a range of other amino acid 255 
substitutions were tolerated, most of these substitutions (e.g. K210A, K210V, K210M, K210N) 256 
blocked cleavage of the VP1/2A junction, thus the VP1-2A product was stable (see Figs. 4 and 5). In 257 
contrast, the 2A peptide was released from the VP1 in the K210R mutant. Therefore, it appears that 258 
the presence of a positively charged residue (K or R) at residue 210 in VP1 is essential for VP1/2A 259 
cleavage and a negative charge (as in K210E) is less well tolerated by itself and was selected against. 260 
These results are consistent with the strong predominance of the K and R residues at this position in 261 
the “logos plot” generated by Curry et al., (2007) for 3Cpro cleavage sites, with Q at the P1 position, 262 
based on the known sequences of over 100 strains of FMDV.  263 
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Using peptide cleavage assays, the VP1/2A peptide was the most efficiently cleaved substrate for 264 
FMDV 3Cpro (Birtley et al., 2005). However, making the K210A substitution abrogated cleavage of 265 
this peptide, in accordance with the results presented here. Zunszain et al., (2010), have described 266 
additional modifications to the peptide substrate, which corresponds to the VP1/2A junction. 267 
Changing the P2 residue in the cleavage site (corresponding to K210 in VP1) from K to R or to 268 
ornithine (also positively charged) had relatively modest effects on the cleavage rate. However, 269 
substitution to the neutral T residue abrogated cleavage as observed here with the K210 changed to 270 
Q, A, V, M or N (see Table 3, Figs. 4 and 5). 271 
It has been proposed that the FMDV 3Cpro may be a good target for the development of an antiviral 272 
agent (Roqué Rosell et al., 2014). Furthermore, it was shown that compounds that resemble the 273 
peptide substrate can act as an efficient inhibitor of this protease. The presence of a positively charged 274 
residue at the P2 position generated the most effective inhibitors while compounds containing neutral 275 
residues (e.g. G and Q) or a negatively charged residue (E) at this position were much less effective, 276 
consistent with the poor cleavage of the VP1/2A junction seen here in viruses containing equivalent 277 
substitutions.  278 
It is important to note that viable FMDVs with the VP1/2A junction uncleaved can be obtained (as 279 
here, and as described previously for serotype O viruses, Gullberg et al., 2013b; Gullberg et al., 2014). 280 
Thus, it may be wise to focus screens for such antiviral agents on other 3Cpro cleavage sites so that 281 
the block on polyprotein processing is most effective at inhibiting virus replication.  282 
The results presented here demonstrate that the combination of reverse genetics and NGS provides 283 
powerful tools to direct and identify virus adaptation thus permitting novel aspects of the virus 284 
biology to be identified. 285 
 286 
Material and Methods 287 
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Plasmid construction 288 
The structures of plasmids containing full-length FMDV cDNAs used in this study are indicated in 289 
Fig.1. The chimeric pO1K/A22 plasmids (containing the A22 Iraq capsid coding sequences, as used 290 
in Porta et al., 2013; Polacek et al., 2013) in the FMDV O1 Kaufbeuren (O1K) backbone were 291 
generated using the same procedures as used previously for the production of the pO1K/O1M VP1 292 
K210E (Gullberg et al., 2013b). Briefly, the cDNAs corresponding to the A22 VP2-2A coding region 293 
were amplified from pGEM-3Z-A-P1-2A-mIRES-3C (Gullberg et al., 2013a) and pGEM-3Z-A-P1-294 
2A-mIRES-3C VP1K210E (Gullberg et al., 2013b) with primers FMDVA_NheIVP4VP2_Fw and 295 
FMDVA_ApaI2A2B_Re (see Supplementary Table S1) and used to generate the full-length cDNAs 296 
termed pO1K/A22 wt and pO1K/A22 VP1 K210E, respectively (Fig.1). In order to produce 297 
pO1K/A22 2A L2P and the double mutant pO1K/A22 VP1 K210E and 2A L2P, intermediate 298 
plasmids (using pO1K/A22 wt and pO1K/A22 VP1K210E, as described above, as templates) were 299 
generated. This was achieved using the QuikChange site-directed mutagenesis method (with 300 
PfuTurbo DNA polymerase; Stratagene), according to the manufacturer´s instructions, with primers 301 
containing the desired modifications (see Supplementary Table S1, namely FMDVA_2AL2P_Fw 302 
together with FMDVA_2AL2P_Re or FMDVA_VP1K210E_2AL2P_Re). The subsequent steps to 303 
produce the four pO1K/A22 variants were performed essentially as described for the serotype O 304 
plasmid pO1K/O1M VP1 E83K (Gullberg et al., 2014). Plasmids were amplified in E. coli Top10 305 
cells (Invitrogen), purified (Midiprep kit; Thermo Scientific) and verified by sequencing of the capsid 306 
coding region (and for pO1K/A22 VP1 K210E the 2C coding region as well) with a BigDye 307 
Terminator v. 3.1 Cycle Sequencing Kit and a 3500 Genetic Analyzer (Applied Biosystems). 308 
Additional mutations, encoding changes at the VP1/2A junction, were introduced into the pO1K/A22 309 
full-length FMDV cDNA (Fig.1) by site-directed mutagenesis using a megaprimer (146 bp) that was 310 
prepared by PCR using primer O1PN20 and primer 13LPN21, (see Supplementary Table S1), that 311 
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had NNN at the position corresponding to the codon for the VP1 residue 210. This degenerate 312 
megaprimer was used, with the pO1K/A22 full-length cDNA template and PfuTurbo DNA 313 
polymerase (as above) to generate a collection of 9 plasmids encoding a variety of different amino 314 
acids, with diverse properties, in place of VP1 residue K210; this is at position P2 relative to the 315 
VP1/2A cleavage site. The details of each modification made are indicated in Table 3. 316 
 317 
Rescue of modified viruses from cDNA. 318 
Plasmids pO1K/A22 (wt), pO1K/A22 VP1 210E, pO1K/A22 2A L2P and pO1K/A22 VP1 K210E 319 
2A L2P, (as shown in Fig.1) containing the full-length FMDV cDNA sequences were linearized by 320 
digestion with HpaI, purified (using a QIAquick PCR purification kit; Qiagen) and transcribed in 321 
vitro using T7 RNA polymerase (Megascript kit; Ambion). The transcripts were analyzed using 322 
agarose gel electrophoresis and then introduced into baby hamster kidney (BHK) cells by 323 
electroporation as described previously (Nayak et al., 2006; Bøtner et al., 2011). At 2 days post 324 
electroporation, the rescued viruses were harvested and amplified in one, or two, subsequent passages 325 
(Psg 2 and Psg3) in BHK cells. After these passages, viral RNA was extracted (QIAamp RNA blood 326 
mini kit; Qiagen), reverse transcribed using ready-to-go you-prime first-strand beads (GE Healthcare 327 
Life Sciences), and the FMDV cDNA corresponding to the VP2-2A coding region was amplified in 328 
a PCR (Expand high-fidelity PCR system; Roche). Control reactions, lacking reverse transcriptase, 329 
were used to show that the PCR products obtained were derived from the viral RNA and not from 330 
residual DNA template. The amplicons (~2,000 bp) including the entire VP2-2A coding region were 331 
visualized in agarose gels, purified (GeneJET gel extraction kit, Thermo Scientific) and sequenced, 332 
on both strands, as above. Sequences were analysed using Vector NTI software (Invitrogen).  333 
For the library of VP1 K210 mutants, mutant viruses were rescued essentially as described above. 334 
The sequencing covered the VP1-2A coding region (from a PCR product of ca. 700bp) both before 335 
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and after virus rescue. The sequence of the 2C coding region was also determined in selected cases. 336 
The rescued viruses were titrated (and were in most cases ca. 106 to 107 TCID50/ml), in some cases a 337 
4th passage in BHK cells was required to reach this titre. 338 
The rescued serotype O viruses O1K/O1M VP1 E83K and O1K/O1M VP1 K210E viruses have been 339 
described previously (Gullberg et al., 2013b; Gullberg et al., 2014). 340 
 341 
RT-PCR and Next Generation Sequencing (NGS). 342 
For the purpose of NGS, extracted RNA (isolated as described above from virus harvests) was 343 
converted to cDNA using SuperScript III (Invitrogen) with a T27 reverse primer according to the 344 
manufacturer’s protocol. Two cDNA amplicons were prepared by PCR using Phusion DNA 345 
polymerase (Thermo Fisher) with the primers 13-N PN 2 + 10-P PN 30 (Supplementary Table S1) 346 
and separately 8-A PN 200 + 13-N PN 3 (Supplementary Table S1). These overlapping fragments 347 
(ca. 4kb and 4.2kb respectively) correspond to the most of the FMDV genome (downstream of the 348 
poly(C) tract, see Belsham (2005)), including the complete polyprotein coding region (ca. 7kb) but 349 
excluding the S-fragment at the 5'-terminus of the viral genome. The fragments were gel purified, 350 
mixed and then analysed by NGS essentially as described previously (Fahnøe et al., 2014; Hadsbjerg 351 
et al., 2016). The parental sequences of the FMDV chimeric O1K/O1M cDNA (as described by 352 
Gullberg et al., 2013b) was assembled from the O1K sequence (Acc. No. X00871) and the coding 353 
sequence for the O1M capsid proteins (from Acc. No. AY593823) with known differences (see 354 
Gullberg et al., 2013b), while the chimeric O1K/A22 sequence was generated using the O1K 355 
sequence and the A22 Iraq sequence (Carrillo et al., 2005, Acc. No. AY593764.1). The derived 356 
sequences were used as the reference for mapping of sequence reads using Samtools (Li et al., 2009), 357 
VarScan 2 (Koboldt et al., 2012) and VCFtools (Danecek et al., 2011), in succession, in order to 358 
generate consensus sequences from the mapped reads. Subsequently, consensus sequences were 359 
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aligned using MAFFT in Geneious (Biomatters, Auckland, New Zealand). Finally, a combination of 360 
Samtools (Li et al., 2009), Lo-Freq (Wilm et al., 2012) and SnpEff (Cingolani et al., 2012) was used 361 
for downstream single nucleotide variant (SNV) analysis.  362 
 363 
Virus infection of BHK cells.  364 
Virus titers were determined, as tissue culture infectious doses (TCID50), by titration in BHK cells 365 
according to standard procedures (Reed & Muench, 1938).  366 
Monolayers of BHK cells, grown in 35-mm wells, were inoculated with the rescued viruses at a 367 
multiplicity of infection (MOI) of 0.1 TCID50/cell. At the indicated times post infection, cell lysates 368 
were prepared using 20 mM Tris-HCl (pH 8.0), 125 mM NaCl and 0.5% NP-40, and clarified by 369 
centrifugation at 18,000 × g for 10 min at 4°C.  370 
 371 
Immunoblot analysis.  372 
Immunoblotting was performed, using cell lysates, according to standard methods as described 373 
previously (Polacek et al., 2013). Briefly, aliquots of cell lysate were mixed with Laemmli sample 374 
buffer (with 25mM dithiothreitol), the proteins were separated by SDS-PAGE (12.5% or 4-15% 375 
polyacrylamide) and transferred to polyvinylidene difluoride membranes (PVDF, Millipore). Specific 376 
proteins were detected with primary antibodies recognizing: FMDV VP2 (monoclonal antibody 4B2, 377 
a gift from L. Yu, as described by Yu et al., 2011) and FMDV 2A (ABS31; Millipore). Bound proteins 378 
were visualized using appropriate horseradish peroxidase-conjugated secondary antibodies (Dako) 379 
and a chemiluminescence detection kit (ECL Prime, Amersham) with a Chemi-Doc XRS system 380 
(Bio-Rad). 381 
 382 
Immunofluorescence assays.  383 
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Monolayers of BHK cells, grown on glass coverslips in 35-mm well plates, were infected with the 384 
rescued O1K/A22 viruses (MOI 0.1). At 6-8 hrs post infection, the cells were fixed, stained and 385 
mounted as previously described (Gullberg et al., 2013b) using rabbit anti-FMDV A-Iraq serum and 386 
anti-FMDV 2A (ABS31, as above) followed by a donkey Alexa-fluor 568-labelled anti-rabbit IgG 387 
(A10042, Life Technologies). The slides were mounted with Vectashield (VECTOR laboratories) 388 
containing 4′,6-diamidino-2-phenylindole (DAPI) and images were captured using an 389 
epifluorescence microscope.  390 
 391 
Acknowledgements 392 
We wish to thank Li Yu (Chinese Academy of Agricultural Sciences, China) for the anti-VP2 393 
antibody. This work was supported by the Danish Council for Independent Research-Technology and 394 
Production Sciences (FTP grant 09-070549) to CP and GJB. 395 
  396 
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.82
On: Wed, 23 Nov 2016 10:01:54
18 
 
References 397 
Abrams, C.C., King, A.M. & Belsham, G.J. (1995). Assembly of foot-and-mouth disease virus 398 
empty capsids synthesized by a vaccinia virus expression system. J Gen Virol 76, 3089-3098. 399 
 400 
Atkins, J.F., Wills, N.M. Loughran, G., Wu, C.Y., Parsawar, K.,  Ryan, M.D., Wang, C.H. & 401 
Nelson, C.C. (2007). A case for “StopGo”: reprogramming translation to augment codon meaning of 402 
GGN by promoting unconventional termination (Stop) after addition of glycine and then allowing 403 
continued translation (Go). RNA 13, 803-810. 404 
 405 
Belsham, G.J. (2005). Translation and replication of FMDV RNA. Curr Top Microbiol Immunol 406 
288, 43-70. 407 
 408 
Birtley, J.R., Knox, S.R., Jaulent, A.M., Brick, P., Leatherbarrow, R.J. & Curry S. (2005). 409 
Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism 410 
and cleavage specificity. J Biol Chem 280, 11520-11527. 411 
 412 
Bøtner, A., Kakker, N.K., Barbezange, C., Berryman, S., Jackson, T. & Belsham, G.J. (2011). 413 
Capsid proteins from field strains of foot-and-mouth disease virus confer a pathogenic phenotype in 414 
cattle on an attenuated, cell-culture-adapted virus, O1 Kaufbeuren virus. J Gen Virol 92, 1141-1151. 415 
 416 
Carrillo, C., Tulman, E.R., Delhon, G., Lu, Z., Carreno, A., Vagnozzi, A., Kutish, G.F. & Rock, 417 
D.L. (2005). Comparative genomics of foot-and-mouth disease virus. J Virol 79, 6487-6504. 418 
 419 
Cingolani, P., Platts, A., Wang, L.L., Coon, M., Nguyen, T., Wang, L., Land, S.J., Lu, X. & 420 
Ruden, D.M. (2012). A program for annotating and predicting the effects of single nucleotide 421 
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.82
On: Wed, 23 Nov 2016 10:01:54
19 
 
polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. 422 
Fly (Austin). 6, 80-92. 423 
 424 
Curry, S., Abrams, C.C., Fry, E., Crowther, J.C., Belsham, G.J., Stuart, D.I. & King, A.M. 425 
(1995). Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. J Virol 69, 426 
430-438. 427 
 428 
Curry, S., Roque-Rosell, N., Zunszain, P.A. & Leatherbarrow, R.J. (2007). Foot-and-mouth 429 
disease virus 3C protease: recent structural and functional insights into an antiviral target. Int J 430 
Biochem Cell Biol 39, 1-6. 431 
 432 
Danecek, P., Auton, A., Abecasis, G., Albers, C.A., Banks, E., DePristo, M.A., Handsaker, R.E., 433 
Lunter, G., Marth, G.T., Sherry, S.T., McVean, G. & Durbin, R. (2011). The variant call format 434 
and VCFtools. Bioinformatics. 27, 2156–2158.  435 
 436 
Donnelly, M.L., Luke, G., Mehrotra, A., Li, X., Hughes, L.E., Gani, D. & Ryan MD. (2001). 437 
Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic 438 
reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol 82, 1013-1025. 439 
 440 
Ellard, F.M., Drew, J., Blakemore, W.E., Stuart, D.I. & King, A.M. (1999). Evidence for the role 441 
of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids. J 442 
Gen Virol 80, 1911-1918. 443 
 444 
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.82
On: Wed, 23 Nov 2016 10:01:54
20 
 
Fahnøe, U., Pedersen, A.G., Risager, P.C., Nielsen, J., Belsham, G.J., Höper, D., Beer, M. & 445 
Rasmussen, T.B. (2014). Rescue of the highly virulent classical swine fever virus strain "Koslov" 446 
from cloned cDNA and first insights into genome variations relevant for virulence. Virology 468-470, 447 
379-387. 448 
 449 
Gullberg, M., Muszynski, B., Organtini, L.J., Ashley, R.E., Hafenstein, S.L., Belsham, G.J. & 450 
Polacek C. (2013a). Assembly and characterization of foot-and-mouth disease virus empty capsid 451 
particles expressed within mammalian cells. J Gen Virol 94, 1769-1779. 452 
 453 
Gullberg, M., Polacek, C., Bøtner, A. & Belsham, G.J. (2013b). Processing of the VP1/2A junction 454 
is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: 455 
characterization of "self-tagged" particles. J Virol 87, 11591-11603. 456 
 457 
Gullberg, M., Polacek, C. & Belsham, G.J. (2014). Sequence adaptations affecting cleavage of the 458 
VP1/2A junction by the 3C protease in foot-and-mouth disease virus-infected cells. 459 
J Gen Virol 95, 2402-2410.  460 
 461 
Hadsbjerg, J., Friis, M.B., Fahnøe, U., Nielsen, J., Belsham, G.J. & Rasmussen, T.B. (2016). 462 
Sequence adaptations during growth of rescued classical swine fever viruses in cell culture and within 463 
infected pigs. Vet Micro 192, 123-134.   464 
 465 
Koboldt, D., Zhang, Q., Larson, D., Shen, D., McLellan, M., Lin, L., Miller, C., Mardis, E., 466 
Ding, L. & Wilson, R. (2012). VarScan 2: Somatic mutation and copy number alteration discovery 467 
in cancer by exome sequencing. Genome Research 22, 568-576. URL:http://varscan.sourceforge.net 468 
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.82
On: Wed, 23 Nov 2016 10:01:54
21 
 
 469 
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., 470 
Durbin, R. & 1000 Genome Project Data Processing Subgroup. (2009). The Sequence 471 
Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079. 472 
 473 
Liu, Y., Wang, C., Mueller, S., Paul, A.V., Wimmer, E. & Jiang, P. (2010) Direct interaction 474 
between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for 475 
enterovirus morphogenesis. PLoS Pathog. 6(8), e1001066.  476 
 477 
Medina, M., Domingo, E., Brangwyn, J.K. & Belsham, G.J. (1993). The two species of the foot-478 
and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 479 
194, 355-359. 480 
 481 
Nayak, A., Goodfellow, I.G., Woolaway, K.E., Birtley, J., Curry, S. & Belsham, G.J. (2006). 482 
Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg 483 
uridylylation and virus replication. J Virol 80, 9865-9875. 484 
 485 
Polacek, C., Gullberg, M., Li, J. & Belsham, G.J. (2013). Low levels of foot-and-mouth disease 486 
virus 3C protease expression are required to achieve optimal capsid protein expression and processing 487 
in mammalian cells. J Gen Virol 94, 1249-1258. 488 
 489 
Porta, C., Xu, X., Loureiro, S., Paramasivam, S., Ren, J., Al-Khalil, T., Burman, A., Jackson, 490 
T., Belsham, G.J., Curry, S., Lomonossoff, G.P., Parida, S., Paton, D., Li, Y., Wilsden, G., 491 
Ferris, N., Owens, R., Kotecha, A., Fry, E., Stuart, D.I., Charleston, B. & Jones, I.M. (2013). 492 
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.82
On: Wed, 23 Nov 2016 10:01:54
22 
 
Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down 493 
regulation of 3C protease activity. J Virol Methods. 187, 406-412.  494 
 495 
Reed, L.J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am J Hyg 496 
27, 493-497. 497 
 498 
Roqué Rosell, N.R., Mokhlesi, L., Milton, N.E., Sweeney, T.R., Zunszain, P.A., Curry, S. & 499 
Leatherbarrow, R.J. (2014). Design and synthesis of irreversible inhibitors of foot-and-mouth 500 
disease virus 3C protease. Bioorg Med Chem Lett. 24, 490-494.  501 
 502 
Ryan, M.D., Belsham, G.J. & King, A.M. (1989). Specificity of enzyme-substrate interactions in 503 
foot-and-mouth disease virus polyprotein processing. Virology 173, 35-45. 504 
 505 
Strebel, K. & Beck E. (1986). A second protease of foot-and-mouth disease virus. J Virol 58, 893-506 
899. 507 
 508 
Wang, C., Jiang, P., Sand, C., Paul, A.V. & Wimmer, E. (2012) Alanine scanning of poliovirus 509 
2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for 510 
morphogenesis. J Virol. 86, 9964-9975. 511 
 512 
Wang C, Ma HC, Wimmer E, Jiang P & Paul AV. (2014) A C-terminal, cysteine-rich site in 513 
poliovirus 2C(ATPase) is required for morphogenesis. J Gen Virol. 95, 1255-1265. 514 
 515 
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.82
On: Wed, 23 Nov 2016 10:01:54
23 
 
Wilm, A., Aw, P.P., Bertrand, D., Yeo, G.H., Ong, S.H., Wong, C.H., Khor, C.C., Petric, R., 516 
Hibberd, M.L. & Nagarajan, N. (2012). LoFreq: a sequence-quality aware, ultra-sensitive variant 517 
caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucl. 518 
Acids Res. 40, 11189-11201. 519 
 520 
Yu, Y., Wang, H., Zhao, L., Zhang, C., Jiang, Z. & Yu, L. (2011). Fine mapping of a foot-and-521 
mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2. J 522 
Microbiol 49, 94-101. 523 
 524 
Zunszain, P.A., Knox, S.R., Sweeney, T.R., Yang, J., Roque-Rosell, N., Belsham, G.J., 525 
Leatherbarrow, R.J. & Curry, S. (2010). Insights into cleavage specificity from the crystal structure 526 
of foot-and-mouth disease virus 3C protease complexed with a peptide substrate. J Mol Biol 395, 527 
375-389. 528 
  529 
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.82
On: Wed, 23 Nov 2016 10:01:54
24 
 
TABLES 530 
Table 1. Analysis of SNVs within rescued O1K/O1M viruses as determined by NGS. 531 
 532 
1: The percentage of each variant (≥ 1%) is given to the nearest integer. 533 
  534 
Nt 
position 
wt Variant O1K/O1M 
VP1 E83K 
(Psg 2) 
 O1K/O1M 
VP1 K210E 
(Psg 2) 
O1K/O1M 
VP1 K210E 
(Psg 3)  
SNV effect 
(whole 
polyprotein) 
SNV effect 
(individual 
protein) 
(%)1 (%)1 (%)1 
762 T C 6 - - (in 5' UTR)  - 
948 T G - 1 3 (in 5' UTR) - 
1811 T C 6 - - - - 
1875 A G 3 - - T253A VP4 (T52A) 
2102 C T 3 - - - - 
2357 A G - 3 3 - - 
3537 G A 100 78 99 E807K VP1 (E83K) 
3918 A G - 100 100 K934E VP1 (K210E) 
3920 A C 4 - - K934N VP1 (K210N) 
3920 A T 9 - - K934N VP1 (K210N) 
3928 T C 83 - - L937P 2A (L2P) 
5166 A G 3 - - S1350G 2C (S243G) 
7392 T C - 5 7 F2092L 3D (F228L) 
7765 A G 2 - - K2216R 3D (K353R) 
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Table 2. Analysis of SNVs within rescued O1K/A22 viruses as determined by NGS. 535 
Nt 
position 
wt Variant O1K/A22 
(wt) 
O1K/A22 
2A L2P  
O1K/A22 VP1 
K210E 2A L2P  
SNV effect 
(whole 
polyprotein) 
SNV effect 
(individual 
protein) (Psg 2) (Psg 3) (Psg 3) 
(%)1 (%)1 (%)1 
932 A C - 2 - (in 5'-UTR) - 
1060 T G 2 - - (in 5'-UTR) - 
1124 T A - 7 - N2K L (N2K) 
1341 C T - - 4 P75S L (P75S) 
1400 G T - - 2 - - 
1865 C T - 2 - - - 
2175 T C - 2 - F353L VP2 (F67L) 
2342 A G - - 2 - - 
2684 C T - 3 - - - 
3154 T C  1 - V679A VP3 (V174A) 
3824 G C 2 - - - - 
3884 T C - 8 - - - 
3921 A G - - 100 K935E VP1 (K210E) 
3930 T C - 90 100   
3931 T C - 98 100 L938P2 2A (L2P)2 
3932 G A - 99 100   
4572 A G - 13 - T1152A 2C (T44A) 
4660 C T - - 100 A1181V 2C (A73V) 
4821 A C - 1 - I1235L 2C (I127L) 
4843 G T - 1 - R1242I 2C (R134I) 
5080 C T - 5 - T1321I 2C (T213I) 
6924 C T - 11 - - - 
7170 T C 3 - - Y2018H 3D (Y155H) 
7358 C T - - 4 - - 
 536 
1: The percentage of each variant (≥ 1%) is given to the nearest integer. 537 
2: Change of the TTG to CCA codon was introduced by site-directed mutagenesis and the 3 538 
changes together result in the 2A (L2P) substitution. 539 
 540 
  541 
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Table 3. Influence of residue K210 in VP1 on VP1/2A junction cleavage in FMDV-infected 542 
cells. 543 
Virus 
VP1 
210 
codon 
Viability 
Rescued 
virus 
sequence 
Rescued 
virus 
amino 
acid 
Comment 
VP1/2A 
cleavage1 
pO1K/A22 K210 AAA + AAA K wt + 
pO1K/A22 K210Q CAA2 + CAA Q  - 
pO1K/A22 K210R AGA2 + AGA R  + 
pO1K/A22 K210A(v1)3 GCA2 + GCA A  - 
pO1K/A22 K210A(v2)3 GCG2 + GCG A  - 
pO1K/A22 K210V GTT2 + GTT V  - 
pO1K/A22 K210M ATG2 + ATG M  - 
pO1K/A22 K210N AAC2 + AAC N  - 
pO1K/A22 K210E(v1)3 GAA2 + AAA K Reversion + 
pO1K/A22 K210E(v2)3 GAG2 + GAG E  - 
 544 
1: VP1/2A cleavage was assessed from IF staining using anti-2A antibodies (as in Fig. 4) and by 545 
immunoblotting (Fig. 5(a)).  546 
2: nt changes in this codon are indicated in bold font. 547 
3: (v1 or v2 to distinguish different codons) 548 
  549 
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Figure legends 550 
 551 
Figure 1. Schematic structure of the plasmid containing the FMDV O1K/A22 cDNA and 552 
derivatives. The NheI and ApaI restriction enzyme sites (as indicated) were used as described in 553 
Materials and Methods to introduce cDNA fragments encoding the serotype A FMDV capsid proteins 554 
VP2-VP3-VP1-2A (from A22 Iraq, white fill) into the plasmid pT7S3 (Ellard et al., 1999), containing 555 
a full-length cDNA corresponding to the O1Kaufbeuren B64 strain of FMDV (coding sequences 556 
marked in grey). The plasmid encoded amino acid sequences at the VP1/2A junction are shown. The 557 
FMDV O1K/A22 wild-type, single mutants (VP1 K210E or 2A L2P) and double mutant (VP1 K210E 558 
and 2A L2P) were produced as described in Materials and Methods. The full-length plasmids were 559 
linearized using HpaI prior to in vitro transcription and virus rescue. The locations of restriction sites 560 
used are marked: NheI, ApaI and HpaI. Sequence changes in the capsid coding region of the rescued 561 
viruses are indicated. 562 
 563 
Figure 2. Detection of FMDV capsid proteins in BHK cells infected with O1K/A22 wild-type 564 
and mutant viruses. BHK cells were infected with O1K/A22 wild-type or mutant viruses (single 565 
mutant 2A L2P or double mutant VP1 K210E and 2A L2P) (MOI of 0.1) and whole cell lysates were 566 
prepared at the indicated times post infection. The presence of FMDV VP2 (and its precursor VP0) 567 
were detected by immunoblotting using anti-VP2 antibodies (panel (a)) and FMDV 2A (attached to 568 
VP1 as VP1-2A) was detected using anti-2A antibodies (panel (b)). Uninfected BHK cells were used 569 
as a negative control. Molecular mass markers (kDa) are indicated on the left. 570 
 571 
Figure 3. Immunofluorescence staining of FMDV proteins within serotype A FMD virus-572 
infected cells. FMDV proteins within uninfected or FMDV-infected cells (using MOI of 0.1) were 573 
detected (at 8 h p.i.) using an anti-FMDV A-Iraq polyclonal antibody (panels (a) - (d)) or an anti-2A 574 
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antibody (panels (e) - (h)) and a secondary antibody labeled with Alexa Fluor 568 (red). Uninfected 575 
cells are shown in panels (a) and (e). Cells were infected with the viruses O1K/A22 (wild-type) 576 
(panels (b) and (f)), O1K/A22 2A L2P (panels (c) and (g)) or O1K/A22 VP1 K210E and 2A L2P 577 
(panels (d) and (h)) as indicated. The cellular nuclei were visualized with DAPI (blue). Bar, 50 μm. 578 
 579 
Figure 4. Determination of VP1/2A cleavage by immunofluorescence staining for FMDV 580 
proteins within cells. FMDV proteins within uninfected or FMDV-infected cells (using MOI of 581 
0.1) were detected (at 6 h p.i.) using an anti-FMDV A-Iraq polyclonal antibody or an anti-2A 582 
antibody (as indicated) and a secondary antibody labeled with Alexa Fluor 568 (red) as in Fig. 3. 583 
The codon for residue 210 within VP1 (in parentheses) and the resulting individual amino acid 584 
residue within the different rescued viruses are indicated. Uninfected cells were used as a negative 585 
control. The cellular nuclei were visualized with DAPI (blue). Bar, 200 μm. 586 
 587 
Figure 5. Assessment of FMDV VP1/2A cleavage in FMDV-infected BHK cells by 588 
immunoblotting. Uninfected or FMDV-infected BHK cell lysates were analysed by SDS-PAGE 589 
and immunoblotting (as in Fig. 2). Where applicable, the cells were infected with the indicated 590 
viruses (at an MOI of 0.1) and the presence of FMDV 2A (attached to VP1 as VP1-2A) was 591 
detected using anti-2A antibodies (panel (a)) while FMDV VP2 (and its precursor VP0) were 592 
detected by immunoblotting using anti-VP2 antibodies (panel (b)). Uninfected cells were used as a 593 
negative control. Molecular mass markers (kDa) are indicated on the left. 594 
 595 
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pO1K/A22 cDNA
pO1K/A22 wild-type (wt)         APAKQ/LLNFD         APAKQ/LLNFD
pO1K/A22 VP1 K210E               APAEQ/LLNFD         APAKQ/LLNFD (reversion)  
pO1K/A22 2A L2P                      APAKQ/LPNFD         APAKQ/LPNFD
pO1K/A22 VP1 K210E 2A L2P  APAEQ/LPNFD         APAEQ/LPNFD
Encoded sequence        Rescued virus
VP2 VP3 VP1 2A
A(n)
L   VP4   VP2         VP3        VP1  2A2B      2C      3A 3B1-3      3C         3DT7
NheI ApaI HpaI
P1-2A
Figure 1 Click here to download Figure Kristiansenetal2016typeAVP1-
2AFig1finalv2.pptx
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Figure 2 Click here to download Figure Kristensenetal2016typeAVP1Fig2final.pptx 
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Fig. 3
Figure 3 Click here to download Figure Kristensenetal2016typeAVP1-2AFig3final.pptx 
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Figure 4 Click here to download Figure
Kristensenetal2016typeAVP1-2AFig4finalv2.pptx
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Figure 5 Click here to download Figure Kristensenetal2016typeAVP1-2AFig5final.pptx 
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Supplementary Table S1. Primers used for plasmid construction and cDNA synthesis  
 
Primer name Sequence (5´-3´) 
FMDVA_NheIVP4VP2_Fw CGCTCTGCTAGCCGATAAGAAGACCGAGGAGACCA 
FMDVA_ApaI2A2B_Re CTACTAGGGCCCGGGGTTGGACTCAACGTCTCCTG 
FMDVA_2AL2P_Fw CAACTTCCAAACTTCGATTTGCTCAAGTTGGCAGGAGAC 
FMDVA_2AL2P_Re GAAGTTTGGAAGTTGTTTTGCAGGTGCAATGATCTTCTG 
FMDVA_VP1K210E_2AL2P_Re GAAGTTTGGAAGTTGTTCTGCAGGTGCAATGATCTTCTG 
13-N PN2 AAGTTTTACCGTCGTTCCCGACGTAAAAGGGAGGTAACCAC
AAGCTTGAA 
  
10-P PN 30 TCTGGACAGCACCTTTGTCG 
8-A PN 200 
 
GAGACGTTGAGTCCAACCC 
13-N PN 3 CCGTAGGAGTGAAAATCCCGAAAGGGTTTTTCCCGCTTCCTT
AATCCAAA 
O1PN20 
 
GACATGTCCTCCTGCATCTG 
13LPN21 GCACCTGCANNNCAACTTTTGAAC 
a Underlined sequences represent restriction enzyme sites NheI and ApaI. Nucleotide changes 
producing amino acids substitutions are shown in boldface italics.     
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